| For: | Abd El-Haleim EA, Bahgat AK, Saleh S. Resveratrol and fenofibrate ameliorate fructose-induced nonalcoholic steatohepatitis by modulation of genes expression. World J Gastroenterol 2016; 22(10): 2931-2948 [PMID: 26973390 DOI: 10.3748/wjg.v22.i10.2931] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i10/2931.htm |
| Number | Citing Articles |
| 1 |
Putri Anggreini, Hadi Kuncoro, Sri Sumiwi, Jutti Levita. Role of the AMPK/SIRT1 pathway in non‑alcoholic fatty liver disease (Review). Molecular Medicine Reports 2022; 27(2) doi: 10.3892/mmr.2022.12922
|
| 2 |
Virginia Anagnostopoulou, Christoforos K. Travlos, Lucas Lage Marinho, Thomas A. Mavrakanas, João Pedro Ferreira, Abhinav Sharma. Therapies for Cardiovascular‐Kidney‐Liver‐Metabolic Syndrome: Reappraisal of Fibrates. Diabetes, Obesity and Metabolism 2026; doi: 10.1111/dom.71230
|
| 3 |
Hala Attia, Norah Albekairi, Layal Albdeirat, Arwa Soliman, Reem Rajab, Hend Alotaibi, Rehab Ali, Amira Badr, Jolanta Czuczejko. Chrysin Attenuates Fructose‐Induced Nonalcoholic Fatty Liver in Rats via Antioxidant and Anti‐Inflammatory Effects: The Role of Angiotensin‐Converting Enzyme 2/Angiotensin (1‐7)/Mas Receptor Axis. Oxidative Medicine and Cellular Longevity 2022; 2022(1) doi: 10.1155/2022/9479456
|
| 4 |
Ali Mahmoudi, Seyed Adel Moallem, Thomas P. Johnston, Amirhossein Sahebkar, Stéphane Mandard. Liver Protective Effect of Fenofibrate in NASH/NAFLD Animal Models. PPAR Research 2022; 2022 doi: 10.1155/2022/5805398
|
| 5 |
Yen-Wei Chen, Graciel Diamante, Jessica Ding, Thien Xuan Nghiem, Jessica Yang, Sung-Min Ha, Peter Cohn, Douglas Arneson, Montgomery Blencowe, Jennifer Garcia, Nima Zaghari, Paul Patel, Xia Yang. PharmOmics: A species- and tissue-specific drug signature database and gene-network-based drug repositioning tool. iScience 2022; 25(4) doi: 10.1016/j.isci.2022.104052
|
| 6 |
Zongying Li, Shuyi Cao. Pre-incubation with human umbilical cord derived mesenchymal stem cells-exosomes prevents cisplatin-induced renal tubular epithelial cell injury. Aging 2020; 12(18) doi: 10.18632/aging.103545
|
| 7 |
Yasmine A Abdelhamid, Mohammed F Elyamany, Muhammad Y Al-Shorbagy, Osama A Badary. Effects of TNF-α antagonist infliximab on fructose-induced metabolic syndrome in rats. Human & Experimental Toxicology 2021; 40(5) doi: 10.1177/0960327120969960
|
| 8 |
Jan Soukop, Ludmila Kazdová, Martina Hüttl, Hana Malínská, Irena Marková, Olena Oliyarnyk, Denisa Miklánková, Soňa Gurská, Zuzana Rácová, Martin Poruba, Rostislav Večeřa. Beneficial Effect of Fenofibrate in Combination with Silymarin on Parameters of Hereditary Hypertriglyceridemia-Induced Disorders in an Animal Model of Metabolic Syndrome. Biomedicines 2025; 13(1) doi: 10.3390/biomedicines13010212
|
| 9 |
P.B. Apoorva, B. Sajeev Kumar, P. Sathishbabu. Next-generation lipid nanoplatforms for phytoconstituent delivery in MASLD management. Journal of Drug Delivery Science and Technology 2026; 124 doi: 10.1016/j.jddst.2026.108615
|
| 10 |
Doaa Abdelmoneim, Ehab B. Eldomany, Mohamed El-Adl, Ahmed Farghali, Gehad El-Sayed, El Said El-Sherbini. Possible protective effect of natural flavanone naringenin-reduced graphene oxide nanosheets on nonalcoholic fatty liver disease. Naunyn-Schmiedeberg's Archives of Pharmacology 2025; 398(4) doi: 10.1007/s00210-024-03495-9
|
| 11 |
Alfredo Fernández-Quintela, Marcela González, Leixuri Aguirre, Iñaki Milton-Laskibar, Asier Léniz, Maria P. Portillo. The Liver. 2018; doi: 10.1016/B978-0-12-803951-9.00017-3
|
| 12 |
Yu-Cheng Li, Jing-Yi Qiao, Bao-Ying Wang, Ming Bai, Ji-Duo Shen, Yong-Xian Cheng. Paeoniflorin Ameliorates Fructose-Induced Insulin Resistance and Hepatic Steatosis by Activating LKB1/AMPK and AKT Pathways. Nutrients 2018; 10(8) doi: 10.3390/nu10081024
|
| 13 |
Pengyuan Zhang, Lijuan Xu, Hongyu Guan, Liehua Liu, Juan Liu, Zhimin Huang, Xiaopei Cao, Zhihong Liao, Haipeng Xiao, Yanbing Li. Beraprost sodium, a prostacyclin analogue, reduces fructose-induced hepatocellular steatosis in mice and in vitro via the microRNA-200a and SIRT1 signaling pathway. Metabolism 2017; 73 doi: 10.1016/j.metabol.2017.05.003
|
| 14 |
Nikolaos Perakakis, Wael Ghaly, Natia Peradze, Chrysoula Boutari, Saime Batirel, Vivian Paraskevi Douglas, Christos S. Mantzoros. Research advances in metabolism 2017. Metabolism 2018; 83 doi: 10.1016/j.metabol.2018.01.018
|
| 15 |
Tanja Eberhart, Miriam J. Schönenberger, Katharina M. Walter, Khanichi N. Charles, Phyllis L. Faust, Werner J. Kovacs. Peroxisome-Deficiency and HIF-2α Signaling Are Negative Regulators of Ketohexokinase Expression. Frontiers in Cell and Developmental Biology 2020; 8 doi: 10.3389/fcell.2020.00566
|
| 16 |
Reza Afarin, Fereshteh Aslani, Shahla Asadizade, Bahar Jaberian Asl, Mehrnoosh Mohammadi Gahrooie, Elham Shakerian, Akram Ahangarpour. The Effect of Lipopolysaccharide-Stimulated Adipose-Derived Mesenchymal Stem Cells on NAFLD Treatment in High-Fat Diet-Fed Rats. Iranian Journal of Pharmaceutical Research 2023; 22(1) doi: 10.5812/ijpr-134807
|
| 17 |
Alba Serrano, Joan Ribot, Andreu Palou, M. Luisa Bonet. Long-term programming of skeletal muscle and liver lipid and energy metabolism by resveratrol supplementation to suckling mice. The Journal of Nutritional Biochemistry 2021; 95 doi: 10.1016/j.jnutbio.2021.108770
|
| 18 |
Ali Mahmoudi, Tannaz Jamialahmadi, Thomas P. Johnston, Amirhossein Sahebkar. Impact of fenofibrate on NAFLD/NASH: A genetic perspective. Drug Discovery Today 2022; 27(8) doi: 10.1016/j.drudis.2022.05.007
|
| 19 |
Pan Li, Ruoyu Zhang, Meng Wang, Yuwei Chen, Zhiwei Chen, Xiumei Ke, Ling Zuo, Jianwei Wang. Baicalein Prevents Fructose-Induced Hepatic Steatosis in Rats: In the Regulation of Fatty Acid De Novo Synthesis, Fatty Acid Elongation and Fatty Acid Oxidation. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.917329
|
| 20 |
Babalwa Unice Jack, Pritika Ramharack, Christiaan Malherbe, Kwazi Gabuza, Elizabeth Joubert, Carmen Pheiffer. Cyclopia intermedia (Honeybush) Induces Uncoupling Protein 1 and Peroxisome Proliferator-Activated Receptor Alpha Expression in Obese Diabetic Female db/db Mice. International Journal of Molecular Sciences 2023; 24(4) doi: 10.3390/ijms24043868
|
| 21 |
Asier Léniz, Daniel Martínez-Maqueda, Alfredo Fernández-Quintela, Jara Pérez-Jiménez, María P. Portillo. Potential Relationship between the Changes in Circulating microRNAs and the Improvement in Glycaemic Control Induced by Grape Pomace Supplementation. Foods 2021; 10(9) doi: 10.3390/foods10092059
|
| 22 |
Elena-Larisa Zimbru, Răzvan-Ionuț Zimbru, Valentin-Laurențiu Ordodi, Florina-Maria Bojin, Daniela Crîsnic, Minodora Andor, Silvia-Nicoleta Mirica, Ioan Huțu, Gabriela Tănasie, Laura Haidar, Daciana Nistor, Luminița Velcean, Virgil Păunescu, Carmen Panaitescu. Rosuvastatin Attenuates Vascular Dysfunction Induced by High-Fructose Diets and Allergic Asthma in Rats. Nutrients 2024; 16(23) doi: 10.3390/nu16234104
|
| 23 |
Adrian Zubrzycki, Agata Wrońska, Anna Kotulak-Chrząszcz, Piotr Mieczysław Wierzbicki, Zbigniew Kmieć. Fenofibrate impairs liver function and structure more pronounced in old than young rats. Archives of Gerontology and Geriatrics 2020; 91 doi: 10.1016/j.archger.2020.104244
|
| 24 |
Mariano Nicolás Alemán, Sara Serafina Sánchez, Stella Maris Honoré. Daily Intake of Smallanthus sonchifolius (Yacon) Roots Reduces the Progression of Non-alcoholic Fatty Liver in Rats Fed a High Fructose Diet. Plant Foods for Human Nutrition 2022; 77(4) doi: 10.1007/s11130-022-01009-7
|
| 25 |
I. Milton-Laskibar, L. Aguirre, U. Etxeberria, F. I. Milagro, J. A. Martínez, María P. Portillo. Involvement of autophagy in the beneficial effects of resveratrol in hepatic steatosis treatment. A comparison with energy restriction. Food & Function 2018; 9(8) doi: 10.1039/C8FO00930A
|
| 26 |
Enas Ahmed Abd El-Haleim. Molecular Study on the Potential Protective Effects of Bee Venom against Fructose-Induced Nonalcoholic Steatohepatitis in Rats. Pharmacology 2020; 105(11-12) doi: 10.1159/000508511
|
| 27 |
Leonie Gellrich, Daniel Merk. Therapeutic Potential of Peroxisome Proliferator-Activated Receptor Modulation in Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis. Nuclear Receptor Research 2017; 4 doi: 10.11131/2017/101310
|
| 28 |
Iman Alqarni, Yieldez A. Bassiouni, Amira M. Badr, Rehab A. Ali. Telmisartan and/or chlorogenic acid attenuates fructose-induced non-alcoholic fatty liver disease in rats: Implications of cross-talk between angiotensin, the sphingosine kinase/sphingoine-1-phosphate pathway, and TLR4 receptors. Biochemical Pharmacology 2019; 164 doi: 10.1016/j.bcp.2019.04.018
|
| 29 |
Chengyuan Liang, Juan Li, Bin Tian, Lei Tian, Yuzhi Liu, Jingyi Li, Liang Xin, Jun Wang, Chao Fu, Zhenfeng Shi, Juan Xia, Yiting Liang, Kun Wang. Foresight regarding drug candidates acting on the succinate–GPR91 signalling pathway for non-alcoholic steatohepatitis (NASH) treatment. Biomedicine & Pharmacotherapy 2021; 144 doi: 10.1016/j.biopha.2021.112298
|
| 30 |
Doaa Abdelmoneim, Mohamed El‐Adl, Gehad El‐Sayed, El Said El‐Sherbini. Protective effect of fenofibrate against high‐fat–high‐fructose diet induced non‐obese NAFLD in rats. Fundamental & Clinical Pharmacology 2021; 35(2) doi: 10.1111/fcp.12597
|
| 31 |
Anishma Karmacharya, Shiho Kasai, Yuuka Mukai, Shin Sato. Maternal Broccoli Powder Intake Ameliorates Insulin Resistance and Inflammation via AMPK/mTOR Pathway in the Livers of High‐Fructose‐Fed Male Rat Offspring Exposed to Maternal Protein Restriction. Molecular Nutrition & Food Research 2024; 68(22) doi: 10.1002/mnfr.202400472
|
| 32 |
Mareca Lodge, Rachel Dykes, Arion Kennedy. Regulation of Fructose Metabolism in Nonalcoholic Fatty Liver Disease. Biomolecules 2024; 14(7) doi: 10.3390/biom14070845
|
| 33 |
Oluwatomilayo Patience Ojo, Paula Andrea Perez-Corredor, Johanna Andrea Gutierrez-Vargas, Oluwole Busayo Akinola, Gloria Patricia Cardona-Gómez. Lasting metabolic effect of a high-fructose diet on global cerebral ischemia. Nutritional Neuroscience 2022; 25(6) doi: 10.1080/1028415X.2020.1841482
|
| 34 |
Kanami Ohshima, Emika Hara, Mio Takimoto, Yidan Bai, Mai Hirata, Wen Zeng, Suzuka Uomoto, Mai Todoroki, Mio Kobayashi, Takuma Kozono, Tetsuhito Kigata, Makoto Shibutani, Toshinori Yoshida. Peroxisome Proliferator Activator α Agonist Clofibrate Induces Pexophagy in Coconut Oil-Based High-Fat Diet-Fed Rats. Biology 2024; 13(12) doi: 10.3390/biology13121027
|
| 35 |
María Sánchez-Aguilar, Luz Ibarra-Lara, Leonardo del Valle-Mondragón, Elizabeth Soria-Castro, Juan Carlos Torres-Narváez, Elizabeth Carreón-Torres, Alicia Sánchez-Mendoza, María Esther Rubio-Ruíz, Sainan Li. Nonclassical Axis of the Renin-Angiotensin System and Neprilysin: Key Mediators That Underlie the Cardioprotective Effect of PPAR-Alpha Activation during Myocardial Ischemia in a Metabolic Syndrome Model. PPAR Research 2020; 2020 doi: 10.1155/2020/8894525
|
| 36 |
Xing Wan, Jingyuan Ma, He Bai, Xuyang Hu, Yanna Ma, Mingjian Zhao, Jifeng Liu, Zhijun Duan. Drug Advances in NAFLD: Individual and Combination Treatment Strategies of Natural Products and Small-Synthetic-Molecule Drugs. Biomolecules 2025; 15(1) doi: 10.3390/biom15010140
|
| 37 |
Milad Ashrafizadeh, Masoud Najafi, Sima Orouei, Amirhossein Zabolian, Hossein Saleki, Negar Azami, Negin Sharifi, Kiavash Hushmandi, Ali Zarrabi, Kwang Seok Ahn. Resveratrol Modulates Transforming Growth Factor-Beta (TGF-β) Signaling Pathway for Disease Therapy: A New Insight into Its Pharmacological Activities. Biomedicines 2020; 8(8) doi: 10.3390/biomedicines8080261
|
| 38 |
Tian Kang, Wei-Li Sun, Xiao-Fei Lu, Xin-Liang Wang, Lian Jiang. MiR-28-5p mediates the anti-proliferative and pro-apoptotic effects of curcumin on human diffuse large B-cell lymphoma cells. Journal of International Medical Research 2020; 48(7) doi: 10.1177/0300060520943792
|
| 39 |
Zhenhua Ma, Yangmin Zhang, Qingchun Li, Meng Xu, Jigang Bai, Shengli Wu, Wenke Feng. Resveratrol improves alcoholic fatty liver disease by downregulating HIF-1α expression and mitochondrial ROS production. PLOS ONE 2017; 12(8) doi: 10.1371/journal.pone.0183426
|
| 40 |
Rasha R. Radwan, Hesham F. Hasan. Pioglitazone ameliorates hepatic damage in irradiated ratsviaregulating anti-inflammatory and antifibrogenic signalling pathways. Free Radical Research 2019; 53(7) doi: 10.1080/10715762.2019.1624742
|
| 41 |
Sabine Weiskirchen, Ralf Weiskirchen. Resveratrol: Is It Really Good for Liver Health?. Hepatitis Monthly 2017; 17(8) doi: 10.5812/hepatmon.12074
|
| 42 |
Zhao Yang, Katherine Roth, Manisha Agarwal, Wanqing Liu, Michael C. Petriello. The transcription factors CREBH, PPARa, and FOXO1 as critical hepatic mediators of diet-induced metabolic dysregulation. The Journal of Nutritional Biochemistry 2021; 95 doi: 10.1016/j.jnutbio.2021.108633
|
| 43 |
Asmaa M. Hamed, Omnyah A. El-Kharashi, Suzi S.A. Boctor, Lobna F. Abd-Elaziz. Potential involvement of PPAR α activation in diminishing the hepatoprotective effect of fenofibrate in NAFLD. Biomedicine & Pharmacotherapy 2017; 85 doi: 10.1016/j.biopha.2016.11.114
|
| 44 |
Yidan Chen, Hui Yu, Xinyu Kai, Runting Yin, Zhen Ouyang, Yuan Wei, Cai Zhang. Oxidative stress in metabolic dysfunction-associated steatohepatitis: Mechanisms and emerging therapeutic strategies. Biochemical Pharmacology 2026; 246 doi: 10.1016/j.bcp.2026.117702
|
| 45 |
Yu Yang, Yu Zhao, Wenzhen Li, Yuyao Wu, Xin Wang, Yijie Wang, Tingmei Liu, Tinghong Ye, Yongmei Xie, Zhiqiang Cheng, Jun He, Peng Bai, Yiwen Zhang, Liang Ouyang. Emerging targets and potential therapeutic agents in non-alcoholic fatty liver disease treatment. European Journal of Medicinal Chemistry 2020; 197 doi: 10.1016/j.ejmech.2020.112311
|
| 46 |
Mohamed A. Tohamy, Hisham R. Muhammed, Mohamed O. Mahmoud. Targeting fibrosis and steatosis: Nebivolol multi-pathway modulator ameliorates experimental non-alcoholic steatohepatitis in rats through AMPK/mTOR and TGF-β1/α-SMA pathways. Bioorganic Chemistry 2025; 163 doi: 10.1016/j.bioorg.2025.108755
|
| 47 |
Luana Cristina Faria Carvalho, Bruna Vidal Bruna, Sttefany Viana Gomes, Cláudia Martins Carneiro, Daniela Caldeira Costa. Temporal effect of fructose supplementation at different concentrations on hepatic metabolism of Wistar rats. Nutrición Hospitalaria 2021; doi: 10.20960/nh.03691
|
| 48 |
Trine V. Dam, Nicolaj I. Toft, Lars Grøntved. Cell-Type Resolved Insights into the Cis-Regulatory Genome of NAFLD. Cells 2022; 11(5) doi: 10.3390/cells11050870
|
| 49 |
Shibin Ding, Jinjin Jiang, Guofu Zhang, Yongjun Bu, Guanghui Zhang, Xiangmei Zhao, Marcia B. Aguila. Resveratrol and caloric restriction prevent hepatic steatosis by regulating SIRT1-autophagy pathway and alleviating endoplasmic reticulum stress in high-fat diet-fed rats. PLOS ONE 2017; 12(8) doi: 10.1371/journal.pone.0183541
|
| 50 |
Kim H.H. Liss, Brian N. Finck. PPARs and nonalcoholic fatty liver disease. Biochimie 2017; 136 doi: 10.1016/j.biochi.2016.11.009
|
| 51 |
CAROLINA A. MIRANDA, TATIELE E. SCHÖNHOLZER, EDUARDO KLÖPPEL, YURI K. SINZATO, GUSTAVO T. VOLPATO, DÉBORA C. DAMASCENO, KLEBER E. CAMPOS. Repercussions of low fructose-drinking water in male rats. Anais da Academia Brasileira de Ciências 2019; 91(1) doi: 10.1590/0001-3765201920170705
|
| 52 |
Aya Galal, Wesam M. El-Bakly, Sara S. El-Kilany, Azza A. Ali, Ebtehal El-Demerdash. Fenofibrate ameliorates olanzapine’s side effects without altering its central effect: emphasis on FGF-21–adiponectin axis. Behavioural Pharmacology 2021; 32(8) doi: 10.1097/FBP.0000000000000656
|
| 53 |
Amanda Karolina Soares Silva, Christina Alves Peixoto. Role of peroxisome proliferator-activated receptors in non-alcoholic fatty liver disease inflammation. Cellular and Molecular Life Sciences 2018; 75(16) doi: 10.1007/s00018-018-2838-4
|
| 54 |
Gabriel Perri Esteves, Camila Sanches Manca, Hellen Paraguassú Veida-Silva, Paula Payão Ovidio, Héric Holland, Flávia Sayuri Matsuo, Mariana Kiomy Osako, Alceu Afonso Jordao. A fish oil-rich diet leads to lower adiposity and serum triglycerides but increases liver lipid peroxidation in fructose-fed rats. Egyptian Liver Journal 2020; 10(1) doi: 10.1186/s43066-020-00045-9
|
| 55 |
Kasimu G. Ibrahim, Eliton Chivandi, Pilani Nkomozepi, Mashudu G. Matumba, Emmanuel Mukwevho, Kennedy H. Erlwanger. The long‐term protective effects of neonatal administration of curcumin against nonalcoholic steatohepatitis in high‐fructose‐fed adolescent rats. Physiological Reports 2019; 7(6) doi: 10.14814/phy2.14032
|
| 56 |
Kento Ogawa, Takashi Yagi, Tingting Guo, Katsushi Takeda, Hideomi Ohguchi, Hiroyuki Koyama, Daisuke Aotani, Kenro Imaeda, Hiromi Kataoka, Tomohiro Tanaka. Pemafibrate, a selective PPARα modulator, and fenofibrate suppress microglial activation through distinct PPARα and SIRT1-dependent pathways. Biochemical and Biophysical Research Communications 2020; 524(2) doi: 10.1016/j.bbrc.2020.01.118
|
| 57 |
Ghedeir M. Alshammari, Aristatile Balakrishnan, Thirunavukkarasu Chinnasamy. Butein protects the nonalcoholic fatty liver through mitochondrial reactive oxygen species attenuation in rats. BioFactors 2018; 44(3) doi: 10.1002/biof.1428
|
| 58 |
Marija Hefer, Nikolina Filipović, Stjepan Šarić, Nela Malatesti, Ana Petrović, Elvira Kovač-Andrić, Martina Smolić. ATR-FTIR Assessment of the Antioxidant and Anti-Inflammatory Effects of (−)-Epicatechin in MASLD. ACS Omega 2026; doi: 10.1021/acsomega.5c09978
|